<DOC>
	<DOCNO>NCT00228462</DOCNO>
	<brief_summary>This study carry see quetiapine ( Seroquel ) effective prevent patient schizophrenic relapse study long time ( 1 year ) , compare non-active treatment .</brief_summary>
	<brief_title>Relapse Prevention , RoW : Study Evaluate Prevention Relapse Patients Stable Chronic Schizophrenia Receiving Either Seroquel Placebo</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Stable schizophrenic patient provide write informed consent Patients 18 65 year old remain clinically stable switch stable dose Seroquel ( quetiapine ) . Patients risk suicide , disorder substance abuse might interfere patient 's ability cooperate , Expected noncompliance treatment Known diabetes mellitus , Contraindications , Intolerance nonresponsiveness Seroquel safety issue .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Schizophrenia</keyword>
</DOC>